Exclusive Coverage

Exclusive Coverage articles provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice.

Nov 23, 2015 4:07 PM
A study in JCO explores how the risk of basal cell carcinoma is affected  by external sources of estrogen and reproductive factors, such as age of first period, which affect the levels of estrogen in a woman’s body.
Oct 26, 2015 4:08 PM
A new study in JOP explores how oncologists use social media, shedding light on the kind of professional knowledge clinicians seek when visiting sites such as Twitter and Facebook and identifying barriers to using social media.
Oct 19, 2015 4:15 PM
This study found that serial imaging is not associated with increased overall survivial among survivors of DLBCL who had achieved complete response (CR).
Sep 30, 2015 9:28 AM
A research team out of Cleveland Clinic carried out an intervention that significantly reduced the time between when patients with febrile neutropenia presented to the emergency department and when those patients received antibiotics.
Sep 08, 2015 4:13 PM
Among the various breast cancer risk assessment tools currently available, the Breast Cancer Surveillance Consortium (BCSC) is the only one to include breast density as a risk factor (click here to see the online risk calculator). However, the BCSC has not included benign breast...
Aug 31, 2015 4:04 PM
A new study in the Journal of Clinical Oncology (JCO) revealed several new findings about the four main symptoms of oxaliplatin-induced acute neuropathy and how these symptoms play out over time among oncology patients in a clinical setting. Neuropathy manifests as pain, numbness, tingling, or muscle weakness in the feet, hands,...
Aug 24, 2015 4:11 PM
Lab studies have shown that gastric cancer cell lines with low levels of ataxia telangiectasia mutated (ATM)—which plays a key role in activating the repair response to DNA damage—are particularly sensitive to olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor. PARP inhibitors target tumors with deficiencies in the repair of double-strand...
Aug 21, 2015 2:40 PM
When Tucker Davis was diagnosed with fibrolamellar hepatocellular carcinoma (FL-HCC) in 2008, there was very little information available about this very rare cancer and, as Tucker would soon discover, even fewer treatment options.
Aug 10, 2015 4:23 PM
A new study in the Journal of Oncology Practice (JOP), “Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison with Middle-Age Cancer Survivors,” found that older patients—defined as 65 and older—differ significantly from younger patients in terms of how they perceive behavioral modifications in smoking and alcohol...